PSY217 - INCREMENTAL QUALITY-ADJUSTED SURVIVAL ANALYSIS WHEN NO HEAD TO HEAD DATA ARE AVAILABLE- A CASE STUDY OF MIDOSTAURIN (MIDO) VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ASM)
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2791
https://www.valueinhealthjournal.com/article/S1098-3015(18)36093-5/fulltext
Title :
PSY217 - INCREMENTAL QUALITY-ADJUSTED SURVIVAL ANALYSIS WHEN NO HEAD TO HEAD DATA ARE AVAILABLE- A CASE STUDY OF MIDOSTAURIN (MIDO) VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ASM)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)36093-5&doi=10.1016/j.jval.2018.09.2791
First page :
Section Title :
Open access? :
No
Section Order :
2147